While the majority of AstraZeneca appointments are still being filled, demand has slowed down, amid concerns about the risk of a rare form of blood clot.
N.S. showing hesitancy around AstraZeneca vaccine, health officials say blood clot risk low
While the majority of AstraZeneca appointments are still being filled, demand has slowed down, amid concerns about the risk of a rare form of blood clot.